Trials / Conditions / Primary Plasma Cell Leukemia
Primary Plasma Cell Leukemia
5 registered clinical trials studyying Primary Plasma Cell Leukemia — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL NCT06333509 | CARsgen Therapeutics Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Mainten NCT06140966 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 |
| Active Not Recruiting | Study of CT071 Injection in RRMM or PPCL NCT05838131 | Shanghai Changzheng Hospital | EARLY_Phase 1 |
| Recruiting | An Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evalua NCT06636552 | Hellenic Society of Hematology | Phase 2 |
| Completed | Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia NCT01553357 | IRCCS Centro di Riferimento Oncologico della Basilicata | Phase 2 |